Al Hummel is a Senior Partner with over 40 years of experience in business and capital markets, particularly in healthcare. He has held leadership roles at several firms and served on boards.
What Al can write
Career
- Merrill Lynch · Vice President
- Bradley-Hummel & Company · CEO, President, Co-Founder, and Board Member
- Watson Pharmaceuticals · Chief Financial Officer
- Cobrek Pharmaceuticals · Chief Executive Officer and Director
- Obagi Medical Products · Chief Executive Officer
- SPRIM Global Investments · Senior PartnerNow
Companies founded
Focus
Education
Also at SPRIM Global Investments
Partners like Al
At firms with a similar stage, sector and check size.
Alert me when SPRIM Global Investments is active
One email when Al's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is Al Hummel?
Al Hummel is a Senior Partner with over 40 years of experience in business and capital markets, particularly in healthcare. He has held leadership roles at several firms and served on boards.
How much does Al Hummel invest?
SPRIM Global Investments has not reported a check size. It invests at series a, series b.
How do I pitch Al Hummel?
A warm intro from a founder SPRIM Global Investments backed works best. A short LinkedIn note with one line on traction is the next best route.
What did Al Hummel do before SPRIM Global Investments?
Vice President at Merrill Lynch; CEO, President, Co-Founder, and Board Member at Bradley-Hummel & Company; Chief Financial Officer at Watson Pharmaceuticals; Chief Executive Officer and Director at Cobrek Pharmaceuticals; Chief Executive Officer at Obagi Medical Products.
Last updated 2026-10-15. Is this you? Ask for a correction.